HOME › DRUGS › MOXETUMOMAB PASUDOTOX-TDFK
ACTIVE SUBSTANCE / INN

MOXETUMOMAB PASUDOTOX-TDFK

Brand name(s): LUMOXITI
FDA LISTED
PRESCRIPTION
BLA761104
ACTIVE SUBSTANCE
Moxetumomab Pasudotox-Tdfk
REGULATORS
FDA
SPONSORS / MAH
INNATE PHARMA
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
LUMOXITIBLA761104INNATE PHARMAPrescription

FULL INTELLIGENCE ON MOXETUMOMAB PASUDOTOX-TDFK

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →